Market Cap | ₹60Cr |
ROE | 1.59% |
P/E Ratio(TTM) | 54.17 |
EPS(TTM) | 0.77 |
P/B Ratio | 2.32 |
Dividend Yield | 0.00% |
Industry P/E | 38.99 |
Book Value | 17.99 |
Debt to Equity | 0.01 |
Face Value | 10 |
Parent Organisation | Bacil Pharma Limited |
BSE Symbol | 524516 |
COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
---|---|---|---|---|
Divi's Laboratories | NA (0.00%) | 65.58 | ||
Neuland Laboratories | NA (0.00%) | 105.04 | ||
Jubilant Pharmova | NA (0.00%) | 36.74 | ||
Acutaas Chemicals | NA (0.00%) | 57.81 |